Seaport Therapeutics, Inc. (SPTX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $5.00K; Additional Paid in Capital, Common StockUSD $625.19M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-475.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $23.83M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $64.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $21.26M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $301.00K.
- 2025-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
Seaport Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $5.00K | $625.19M | $-475.00K | $-202.12M | $422.60M | 3 month · $36.86M |
| 2026-03-31 | (m) | $1.00K | $23.83M | $64.00K | $-139.52M | $-115.62M | 3 month · $2.57M |
| 2025-12-31 | $0.00 | $1.00K | $21.26M | $301.00K | $-114.11M | $-92.55M | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | $-49.55M | 3 month · $1.76M |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | $-36.16M | 3 month · $1.62M |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | $-24.85M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |